INTERPRETATION OF CHANGES IN QUANTITATIVE RATIO OF NEUROTROPIC AUTOANTIBODIES IN PATIENTS WITH COVID-19
Abstract
COVID-19 is a new disease in the history of mankind, the pathogenesis of the development of clinical symptoms, the early and late complications of which are not well understood. Careful observation of patients with COVID-19 has shown that the symptoms of damage to the nervous system in this disease can be varied, however, very little is known about the long-term consequences of COVID-19. Despite a significant variety of methods for studying the nervous system, the effectiveness of most of them remains low in terms of detecting the earliest preclinical changes. It is appropriate to pose the question, is there a method that can indicate with great accuracy that the pathological process has started and there is a tendency for the development of a certain disease even before the appearance of changes in the indications of the traditionally used methods of early diagnosis of this disease? When, under the influence of various etiological factors, the process of cell destruction is accelerated, the immune system begins to produce more autoantibodies so that the clearance process proceeds at an appropriate rate. This is a very important point, since it is the increase in the levels of specific autoantibodies that is the very early and sensitive marker indicating the start of the pathological process long before the appearance of biochemical preclinical shifts. The ELI-Neuro-Test method of immunochemical analysis makes it possible to comprehensively assess the state of neurotransmitter systems and, long before the appearance of neurological or psychiatric symptoms, with a high probability of predicting diseases of the central nervous system, in particular those associated with COVID-19. Using this method, an individual profile of serum immunoreactivity is analyzed, depending on changes in the relative content of IgG autoantibodies directed to 12 autogens of the nervous system. The significant number of people who have had COVID-19 among the population of our country, the neurotropism of the coronavirus and the possibility of developing not only early, but also late complications from the nervous system is a prerequisite for a deeper and more comprehensive study of all the most important aspects of COVID-19 associated lesions of the central nervous system.\n\n